Jones v. Novo Nordisk A/S

UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION IN RE: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION MDL No. 3094 TRANSFER ORDER Before the Panel:* Plaintiffs in nine actions move under

28 U.S.C. § 1407

to centralize this litigation in the Western District of Louisiana. This litigation consists of eighteen actions pending in eleven districts, as listed on Schedule A. In addition, the parties have informed the Panel of 37 related actions pending in fifteen districts. ! The scope of this MDL, should the Panel order centralization, is a primary point…